Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Health Science Center, Shenzhen University, Shenzhen, China.
Expert Opin Drug Deliv. 2022 Nov;19(11):1487-1504. doi: 10.1080/17425247.2022.2134853. Epub 2022 Oct 18.
In recent years, to improve the precision of drug delivery and reduce toxicity associated from the uncontrolled drug release at off-target locations, extensive efforts have been paid to develop stimuli-responsive nanocarriers, which enable precise control over on-demand drug release due to internal stimuli like pH, redox, enzyme and external stimuli like light, magnetic field, and ultrasound. Moreover, some stimuli-responsive nanocarriers have been strategically incorporated with imaging probes for simultaneous monitoring of the drug delivery process and region of interest for treatment optimization.
In this review, the state-of-art progress in developing stimuli-responsive image-guided nanocarriers are summarized, including their designed strategies, synergistic mechanism, and biomedical applications in cancer therapy, and the current challenges and new perspectives are discussed.
The stimuli-responsive nanocarriers provide assurance for precise release of drugs and imaging probes, and the molecular imaging techniques can monitor the pharmacokinetics, biodistribution and bioavailability of drugs , and feedback the drug delivery profile. Therefore, stimuli-responsive image-guided nanocarriers can integrate diagnosis and therapy in one nanoplatform and facilitate optimal therapeutic efficacy.
近年来,为了提高药物输送的精度并降低由于药物在非靶部位失控释放而产生的毒性,人们已经付出了大量努力来开发对刺激响应的纳米载体,这些纳米载体能够由于内部刺激(如 pH 值、氧化还原、酶)和外部刺激(如光、磁场和超声波)来精确控制药物的按需释放。此外,一些对刺激响应的纳米载体已经被策略性地与成像探针结合,用于同时监测药物输送过程和治疗优化的感兴趣区域。
在这篇综述中,总结了开发对刺激响应的图像引导纳米载体的最新进展,包括它们的设计策略、协同机制以及在癌症治疗中的生物医学应用,并讨论了当前的挑战和新的视角。
对刺激响应的纳米载体为药物和成像探针的精确释放提供了保证,而分子成像技术可以监测药物的药代动力学、分布和生物利用度,并反馈药物输送情况。因此,对刺激响应的图像引导纳米载体可以将诊断和治疗整合在一个纳米平台中,促进最佳的治疗效果。